Literature DB >> 15778805

[Anaesthesia in patients with Parkinson's disease].

A Kalenka1, J Hinkelbein.   

Abstract

The neurodegenerative death of dopaminergic neurons of the pars compacta of the substantia nigra leads to the classical triad of resting tremor, muscle rigidity, and bradykinesia of Parkinson's disease. Parkinson's disease is a common disease of elderly patients requiring perioperative anaesthesia. Particular anaesthetic problems are neurological, respiratory, and cardiovascular. The clinical features and the interaction of common anaesthetics with the drug therapy of the patient present an anaesthetic challenge and directly influence perioperative morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778805     DOI: 10.1007/s00101-005-0840-3

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  11 in total

Review 1.  Future and current surgical therapies in Parkinson's disease.

Authors:  Simone A Betchen; Michael Kaplitt
Journal:  Curr Opin Neurol       Date:  2003-08       Impact factor: 5.710

2.  Parkinson's disease and anaesthesia.

Authors:  H Gray; S Wilson; P Sidebottom
Journal:  Br J Anaesth       Date:  2003-04       Impact factor: 9.166

Review 3.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

4.  Propofol-induced dyskinesias in Parkinson's disease.

Authors:  J K Krauss; E W Akeyson; P Giam; J Jankovic
Journal:  Anesth Analg       Date:  1996-08       Impact factor: 5.108

5.  The lack of effect of succinylcholine on serum potassium in patients with Parkinson's disease.

Authors:  D A Muzzi; S Black; R F Cucchiara
Journal:  Anesthesiology       Date:  1989-08       Impact factor: 7.892

6.  Succinylcholine-induced hyperkalemia in a patient with Parkinson's disease.

Authors:  G P Gravlee
Journal:  Anesth Analg       Date:  1980-06       Impact factor: 5.108

7.  Prevalence of movement disorders in elderly community residents.

Authors:  S Moghal; A H Rajput; C D'Arcy; R Rajput
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

8.  Propofol--contrasting effects in movement disorders.

Authors:  B J Anderson; P V Marks; M E Futter
Journal:  Br J Neurosurg       Date:  1994       Impact factor: 1.596

9.  Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

Authors:  M A Eisenberger; B A Blumenstein; E D Crawford; G Miller; D G McLeod; P J Loehrer; G Wilding; K Sears; D J Culkin; I M Thompson; A J Bueschen; B A Lowe
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

10.  Subthalamic stimulation in Parkinson disease: with or without anesthesia?

Authors:  David Maltête; Soledad Navarro; Marie-Laure Welter; Sabine Roche; Anne-Marie Bonnet; Jean-Luc Houeto; Valérie Mesnage; Bernard Pidoux; Didier Dormont; Philippe Cornu; Yves Agid
Journal:  Arch Neurol       Date:  2004-03
View more
  5 in total

Review 1.  [Preoperative long-term therapy].

Authors:  K Buhre; L de Rossi; W Buhre
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

2.  Anaesthetic Management of a Geriatric Patient with Parkinson's Disease, who was Posted for Emergency Laparotomy- A Case Report.

Authors:  Renuka T Holyachi; Santosh Karajagi; Siddanagouda M Biradar
Journal:  J Clin Diagn Res       Date:  2013-01-01

3.  Parkinson's disease influences the perioperative risk profile in surgery.

Authors:  Marcus C Mueller; Ulf Jüptner; Ullrich Wuellner; Stefan Wirz; Andreas Türler; Andreas Hirner; Jens Standop
Journal:  Langenbecks Arch Surg       Date:  2008-08-19       Impact factor: 3.445

Review 4.  [Perioperative management of patients with Parkinson's disease].

Authors:  J Spiegel
Journal:  Orthopade       Date:  2009-09-03       Impact factor: 1.087

Review 5.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.